COMP <GO>
CROX vs NKE // FORWARD P/E MULTIPLE
Crocs Inc. (NASDAQ) VS. Nike Inc. (NYSE) • 15-METRIC TALLY: CROX 3
— NKE 10
▲ FORWARD P/E MULTIPLE LEADER: NKE
LAST: $153.13 (+1.73%) • MKT CAP: $6.88B
forward-pe
32.0x
LAST: $39.12 (+1.16%) • MKT CAP: $57.44B
forward-pe
17.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CROX VS. NKE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CROX | NKE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 58.30% | 42.90% | +15.40 | CROX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 21.20% | -16.30 | NKE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 43.0x | 13.1x | +29.90 | NKE | /valuation <GO> |
| Free Cash Flow Yield | 9.15% | 3.83% | +5.32 | CROX | /fcf-yield <GO> |
| Operating Margin | 3.70% | 8.20% | -4.50 | NKE | /operating-margins <GO> |
| Net Profit Margin | -2.00% | 6.70% | -8.70 | NKE | /net-margins <GO> |
| Revenue Growth (YoY) | -1.50% | 0.20% | -1.70 | NKE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 4.22% | -4.22 | NKE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.81 | 3.82 | -0.01 | NKE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 77.5 | 61.1 | +16.40 | CROX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 1.16 | -0.12 | NKE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 32.0x | 17.1x | +14.90 | NKE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.88B | $57.44B | -$50.55B | NKE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CROX REV | NKE REV | CROX GROSS % | NKE GROSS % | CROX FCF | NKE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.04B | $46.40B | 58.3% | 42.9% | $659.2M | $2.18B |
| FY 2024 | $4.10B | $46.31B | 58.8% | 42.7% | $923.1M | $3.27B |
| FY 2023 | $3.96B | $51.36B | — | — | $752.1M | $5.12B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CROX // BETA 1.04
NKE // BETA 1.16